Brevan Howard Capital Management’s CVS Health CVS Stock Holding History

Brevan Howard Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.4M	Buy	75,187 +61,929	+467%	+$4.77M	0.05%	213
2025 Q4	$1.05M	Buy	13,258 +7,610	+135%	+$600K	0.01%	739
2025 Q3	$426K	Sell	5,648 -77,916	-93%	-$5.34M	﹤0.01%	1375
2025 Q2	$5.76M	Buy	83,564 +72,182	+634%	+$4.73M	0.03%	324
2025 Q1	$771K	Sell	11,382 -13,879	-55%	-$831K	0.01%	588
2024 Q4	$1.13M	Buy	+25,261	New	+$1.42M	0.01%	400
2024 Q2	–	Sell	-23,654	Closed	-$1.89M	–	1118
2024 Q1	$1.89M	Sell	23,654 -150	-0.6%	-$11.5K	0.02%	159
2023 Q4	$1.88M	Buy	23,804 +20,408	+601%	+$1.45M	0.02%	130
2023 Q3	$237K	Buy	+3,396	New	+$241K	﹤0.01%	290

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Brevan Howard Capital Management's CVS Position: Q1 2026 in Review

Brevan Howard Capital Management increased its CVS Health (CVS) stake by 467% in Q1 2026, buying an estimated $4.77M and bringing the position to 75,187 shares worth $5.4M. The position accounts for 0.05% of the portfolio, ranked #213.

Brevan Howard Capital Management first reported a position in CVS in Q3 2023 and has held it in 9 quarters since. The position peaked at $5.76M in Q2 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Brevan Howard Capital Management held 75,187 shares of CVS Health worth $5.4M as of Q1 2026.
Brevan Howard Capital Management bought 61,929 CVS Health shares in Q1 2026, an estimated $4.77M.
CVS Health made up 0.05% of Brevan Howard Capital Management's portfolio in Q1 2026, its #213 holding.
Brevan Howard Capital Management first reported a position in CVS Health in Q3 2023 and has held it in 9 quarters since.
Brevan Howard Capital Management's CVS Health position peaked at $5.76M in Q2 2025.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.